Noah Holdings Limited (NOAH)
시가총액: 623.78M
국가: China
산업: #Investment_Managers
섹터: #Finance
홈페이지: https://www.noah-fund.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 614.59M / -- / -- / -5.4% / 588.2%
2412: 89.31M / -- / -- / -88.8% / -86.9%
2409: 683.69M / -- / -- / -8.8% / 11.0%
2406: 615.85M / -- / -- / -34.6% / -5.2%
2403: 649.54M / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 2.39 / -- / -- / 3.5% / 819.2%
2412: 0.26 / -- / -- / -91.7% / -87.9%
2409: 2.14 / -- / -- / -36.3% / 41.7%
2406: 1.51 / 2.0 / -24.5% / -66.7% / -34.6%
2403: 2.31 / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 3.29B(6.3%) / 14.55(1.7%)
2212: 3.1B(-27.8%) / 14.3(-26.5%)
2112: 4.29B(29.9%) / 19.45(261.9%)
2012: 3.31B(--) / -12.01(--)

#NOAH

- 사업요약: Noah Holdings Limited, together with its subsidiaries, operates as a wealth and asset management service provider with the focus on investment and asset allocation services for high net worth individuals and enterprises in Mainland of China, Hong Kong, and inter...

U-Haul Holding Company (UHAL)
시가총액: 12.20B
국가: United States
산업: #Rental_Leasing_Companies
섹터: #Consumer_Discretionary
홈페이지: https://investors.uhaul.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 1.23B / 1.14B / 7.9% / 4.2% / -11.5%
2412: 1.39B / 1.35B / 3.0% / 3.8% / -16.3%
2409: 1.66B / 1.69B / -1.8% / 0.6% / 7.1%
2406: 1.55B / 1.58B / -1.9% / 0.6% / 31.4%
2403: 1.18B / 1.17B / 0.9% / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.46 / -0.2167 / -112.3% / -820.0% / -231.4%
2412: 0.35 / 0.33 / 6.1% / -23.9% / -63.5%
2409: 0.96 / 1.37 / -29.9% / -29.4% / -4.0%
2406: 1.0 / 1.63 / -38.7% / -21.3% / 2100.0%
2403: -0.05 / 0.11 / -145.5% / -- / --

- 연간 매출(YoY%), EPS(YoY%)
2403: 5.63B(-4.1%) / 3.04(-45.1%)
2303: 5.86B(2.2%) / 5.54(-21.8%)
2203: 5.74B(26.4%) / 7.08(31.8%)
2103: 4.54B(--) / 5.37(--)

#UHAL

- 사업요약: U-Haul Holding Company operates as a do-it-yourself moving and storage operator for household and commercial goods in the United States and Canada. The company's Moving and Storage segment r...

nCino, Inc. (NCNO)
시가총액: 3.08B
국가: United States
산업: #Computer_Software_Prepackaged_Software
섹터: #Technology
홈페이지: https://www.ncino.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2504: 144.14M / 139.82M / 3.1% / 12.5% / 1.9%
2501: 141.4M / 140.85M / 0.4% / 14.3% / 1.9%
2410: 138.8M / 137.34M / 1.1% / 13.8% / 4.8%
2407: 132.4M / 131.06M / 1.0% / 12.9% / 3.4%
2404: 128.09M / 126.64M / 1.1% / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2504: 0.16 / 0.1553 / 3.0% / -15.8% / 33.3%
2501: 0.12 / 0.19 / -36.8% / -- / -42.9%
2410: 0.21 / 0.16 / 31.2% / 240.0% / 50.0%
2407: 0.14 / 0.13 / 7.7% / 200.0% / -26.3%
2404: 0.19 / 0.135 / 40.7% / -- / --

- 연간 매출(YoY%), EPS(YoY%)
2401: 476.54M(16.7%) / -0.38(59.1%)
2301: 408.31M(49.1%) / -0.93(-82.4%)
2201: 273.87M(34.1%) / -0.51(-10.9%)
2101: 204.29M(--) / -0.46(--)

#NCNO

- 사업요약: nCino, Inc., a software-as-a-service company, provides cloud-based software applications to financial institutions in the United States and internationally. Its nCino Bank Operating System conne...

Standard Lithium Ltd. (SLI)
시가총액: 358.61M
국가: Canada
산업: #Major_Chemicals
섹터: #Industrials
홈페이지: https://www.standardlithium.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / 0.00 / -- / -- / --
2412: 0.00 / 0.00 / -- / -- / --
2409: -- / 0.00 / -- / -- / --
2406: -- / 0.00 / -- / -- / --
2403: 0.0 / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.03 / -0.0382 / 21.5% / 50.0% / 76.9%
2412: -0.13 / -0.0349 / -272.5% / -116.7% / -333.3%
2409: -0.03 / -0.04 / 25.0% / 50.0% / -104.0%
2406: 0.7421 / -0.0409 / 1914.4% / -- / 1336.8%
2403: -0.06 / -- / -- / -50.0% / 0.0%

- 연간 매출(YoY%), EPS(YoY%)
2306: 0.0(--) / -0.25(0.0%)
2206: 0.0(--) / -0.25(-19.0%)
2106: 0.0(--) / -0.21(-90.9%)
2006: 0.0(--) / -0.11(--)

#SLI

- 사업요약: Standard Lithium Ltd. explores for, develops, and processes lithium brine properties in the United States. Its flagship project is the South West Arkansas Project and the Phase 1A Project located in southern Arkansas. The company was formerly known as Patriot Petroleum C...

Telomir Pharmaceuticals, Inc. (TELO)
시가총액: 62.5M
국가: United States
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://telomirpharma.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / -- / -- / -- / --
2412: 0.00 / -- / -- / -- / --
2409: -- / -- / -- / -- / --
2403: 0.0 / -- / -- / -- / --
2312: 0.0 / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.07 / -0.06 / -16.7% / 69.6% / 17.6%
2412: -0.085 / -- / -- / -- / --
2409: -- / -- / -- / -- / --
2403: -0.23 / -- / -- / -1310.2% / --
2312: -- / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 0.0(--) / -0.441471(-1430.4%)
2212: 0.0(--) / -0.028847(-518.4%)
2112: 0.0(--) / -0.004665(--)

#TELO

- 사업요약: Telomir Pharmaceuticals, Inc., a preclinical stage pharmaceutical company, is engaged in the advancement of age reversal science. The company is developing Telomir 1, a small molecule intended to lengthen and protect telomeres, the DNA end caps of chromosomes that are associated with cellular aging. Telomir 1 is...